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Abstract.  The recent cloning of complete cDNAs en- 
coding carcinoembryonic antigen (CEA) and non- 
specific cross-reacting antigen has revealed the exis- 
tence of a new gene family belonging to the 
immunoglobulin gene superfamily. We have reported 
the isolation of a partial  CEA cDNA and of L-cell 
transfectant cell lines that express human antigens 
cross-reactive with commercial antibodies directed to 
native CEA (Kamarck,  M., J.  Elting,  J.  Hart,  S.  Goe- 
bel, P. M.  M.  Rae, J.  Nedwin, and T.  Barnett.  1987. 
Proc.  Natl.  Acad.  Sci.  USA.  84:5350-5354).  In this 
study, we describe the identification and cloning of 
3.9-,  3.7-, 2.2-,  and  1.8-kb cDNAs and a 23-kb 
genomic transcription  unit,  which code for new mem- 
bers of the CEA gene family. DNA sequence analysis 
of these cloned DNAs establishes the existence of a 
set of four alternatively spliced mRNAs which are ex- 
pressed in several tumor cell lines,  in human fetal 
liver, and in L-cell transfectants.  Deduced amino acid 
sequences of the encoded isoantigens show extensive 
similarity to CEA and nonspecific cross-reacting anti- 
gens, but in addition demonstrate transmembrane and 
cytoplasmic domains.  We designate members of this 
antigen  family transmembrane' CEAs.  The transmem- 
brane CEA isoantigens  share general  structural  charac- 
teristics with members of the immunoglobulin gene 
superfamily and can be specifically compared to the 
cell adhesion molecules,  N-CAM (neural cell adhesion 
molecule) and MAG (myelin-associated glycoprotein). 
C 
ARCINOEMBRYONIC  antigen (CEA) ~  is a 180-kD gly- 
coprotein that has been used extensively as a serum 
marker in some cancers,  particularly those of colo- 
rectal, breast, and lung origin.  Despite its initial promise as 
a tumor-specific marker,  CEA has been shown to be a mem- 
ber of a family of 8-10 cross-reactive isoantigens  which can 
be detected in a variety of normal and tumor tissue types 
(Shively  and  Beatty,  1985).  CEA  and  nonspecific  cross- 
reacting  antigen  (NCA)  have recently been shown to have 
considerable structural  and sequence similarity  (Engvall et 
al., 1978; Paxton et al., 1987; Thompson et al., 1987), thus 
explaining  their  observed  immunological  cross-reactivity 
among anti-CEA antibodies (von Kleist et al., 1972; Darcy 
et al.,  1973).  This cross-reactivity extends  to all members 
of the CEA isoantigen  family and has made interpretation 
of diagnostic  immunoassays for CEA both difficult and inac- 
curate. 
Axel  Kretschmer's present address is BAYER AG,  ZF-F Biotechnologie 
Q18, D-5090 Leverkusen, FRG. 
1.  Abbreviations  used  in  this paper:  CEA,  carcinoembryonic antigen; 
MAG, myelin-associated glycoprotein;  NCA, nonspecific cross-reacting an- 
tigen; N-CAM, neural cell adhesion molecule; TM-CEA, transmembrane 
carcinoembryonic antigen. 
Recently,  the complete cDNAs for both CEA and  NCA 
have been isolated and sequenced (Beauchemin et al., 1987; 
Oikawa et al.,  1987; Barnett  et al.,  1~88; Neumaier et al., 
1988; Tawaragi et al.,  1988). These antigens display a high 
degree of sequence similarity  and also maintain a repeating 
series of disulfide loops with features of immunoglobulin  su- 
perfamily members (Hunkapiller  and Hood, 1986; Williams 
and Barclay,  1988). Both CEA and NCA have short hydro- 
phobic peptide segments  at their  carboxyl termini,  but ap- 
pear to be anchored in the cell membrane by a glycolipid 
moiety (Takami et al.,  1988). 
We have previously isolated  an  L-cell transfectant  line, 
23.4  11+,  and  a bacteriophage hgtll  partial  cDNA clone 
()~cLV7) that  express  epitopes of CEA  (Kamarck  et  al., 
1987). The partial cDNA clone encompasses the second and 
part  of  the  third  loop  domains  of  CEA  (nucleotides 
1,084-1,916  in Barnett  et al.,  1988) and  identifies  several 
major Eco RI and Barn HI segments in genomic DNA. All 
of these genomic segments map to human chromosome 19, 
suggesting the existence  of a CEA gene locus consisting  of 
an extensive family of related members. In contrast,  cDNA 
from  hcLV7  hybridized  to  a  single  genomic  segment  in 
L-cells that had been transfected with human genomic DNA 
and selected for CEA expression using commercial antibod- 
©  The Rockefeller University Press, 0021-9525/89/02/267/10  $2.00 
The Journal of Cell Biology, Volume 108, February  1989 267-276  267 ies and the fluorescence-activated  cell sorter. These transfec- 
tants expressed CEA family members distinguishable from 
both CEA and NCA based on the molecular sizes of their an- 
tigens and their messenger RNAs  (Kamarck et al.,  1987; 
Barnett et al.,  1988). 
In this study, we describe the cloning of a genomic tran- 
scription unit and of  cDNAs for alternatively spliced mRNAs 
that code for four previously undescribed CEA isoantigens 
expressed by a number of tumor cell lines and by normal fetal 
liver. Despite their extensive amino acid sequence similari- 
ties, the four protein species differ from CEA and NCA in 
that they contain transmembrane and cytoplasmic domains. 
For this reason we have designated these molecules trans- 
membrane CEAs (TM-CEAs). With the identification of this 
new class of CEA glycoproteins, we can now account for six 
of the 8-10 members of the CEA isoantigen family. 
Materials and Methods 
Cells and Cell Lines 
Human tumor cell lines were obtained from the American Type Culture 
Collection (RockviUe,  MD) and grown according to specifications. Line 
designations are LoVo (CCL 229, colon adenocarcinoma), HT-29 (HTB 38, 
colon adenocareinoma), BeWo (CCL 98, choriocarcinoma), SW403  (CCL 
230,  colon adenocarcinoma), KG-1 (CCL 246,  acute myelogenous leuke- 
mia), SCaBER (HTB 3, squamous bladder carcinoma), and MIA PaCa-2 
(CRL  1420,  human pancreatic carcinoma).  The L-cell transfectant line, 
23.4  11+,  has been previously described (Kamarek et al.,  1987). 
D NA Preparation and Analysis 
DNA was extracted from cells essentially as described by DiLella and Woo 
(1987).  DNA (10 #g) was digested at 37°C for 6-8 h with restriction en- 
donucleases (Amersham Corp., Arlington Heights, IL) and subjected to 
electrophoresis through horizontal 0.8 % agarose gels before transfer to ny- 
lon membranes. For the preparation of genomic DNA for library construc- 
tion or subeloning, 100-200 #g of DNA was digested either with excess Eco 
RI or with a predetermined amount of Mbo I (mean DNA size produced 
=  12-15 kb) and subjected to electrophoresis overnight through horizontal 
0.5 % low melting temperature agarose gels for optimal separation. Appro- 
priate size classes were excised with a razor blade, gel slices were melted 
in 0.3 M NaOAc, pH 5, and 0.1 M Tris-HCI, pH 7.8, DNA was purified by 
phenol extraction, precipitated with 95% ethanol, and resuspended in 10 
mM Tris-HCl, pH 7.5,  I  mM EDTA. 
RNA Preparation and Analysis 
Cell pellets stored at -80°C were thawed in the presence of 0.14 M NaC1, 
1.5 mM MgCI2,  10 mM Tris-HCl, pH 7.5, 0.5% NP-40 (Sigma Chemical 
Co.,  St.  Louis,  MO),  4  mM  DTT,  and  10  u/ml  of human  placental 
ribonuclease inhibitor (Stratagene Inc., San Diego, CA). Cells were frac- 
tionated by 20 strokes of a low clearance Dounce-type homogenizer and in- 
cuhated in 0.1% Na deoxycholate for 10 min on ice. Cytoplasmic and nu- 
clear fractions were separated by centrifugation for 20 min at 12,000 g, and 
the supernatant was added to an equal volume of 200 mM Tris-HCl, pH 7.5, 
25 mM EDTA, 300 mM NaC1, 2 % SDS, and 400/~g/ml of proteinase K. 
After incubation at 45 °C, nucleic acids were extracl~xt with phenol/chloro- 
form (1:1 [vol/vol]),  and  ethanol precipitated in the presence of added 
NaOAc to 0.15 M. Poly A+ RNA was prepared by oligo dT column chroma- 
tography as described by Aviv and Leder (1972).  For Northern analysis, nu- 
cleic acids were separated on 2.2 M formaldehyde-0.8  % agarose gels as de- 
scribed by Lehrach et al.  (1977),  then transferred to nylon membranes. 
Probe Preparation and Nucleic Acid Blots 
Mini-preparations of plasmid DNA (Maniatis et al.,  1982) were digested 
with restriction enzymes and fractionated by size on 1% agarose gels. Ap- 
propriate segments were excised from the gel and used directly for random 
priming (Feinberg and Vogelstein, 1984)  in the presence of ot-32p-dCTP 
(6,000  Ci/mmol;  Amersham Corp).  Unincorporated nucleotide was re- 
moved by spun column chromatography over Sephadex G-50 (Pharmacia 
Fine Chemicals, Piscataway,  N J). Probes were used at 106 cpm/ml in 2 × 
SSPE, 5x  Denhardt's, 6%  SDS at 68°C for 24--48  h.  Posthybridization 
washes were in 0.2x  SSPE, 0.25%  SDS at 68°C. 
c D NA Library Construction 
Poly A+ RNAs from 23.411+  transfectant cells and from HT-29 cells were 
converted to double-stranded DNA essentially by the method of Gubler and 
Hoffman (1983).  After Eco RI methylase treatment, DNA was fractionated 
on 0.8 % LGT agarose gels, size selected based on identification of RNA 
from Northern blots, and eluted by melting (see above). Eco RI linkers were 
added and cDNAs were inser~d into Eco RI-cleaved arms of liga~xl ~,gtl0 
DNA. Phage with inserts were selected on the Hfl  + host, NM514. Screen- 
ing of phage was by the method of Benton and Davis (1977) using radiola- 
beled DNA probes. Purified positive phage DNAs were cleaved with Eco 
RI, then inserts were fractionated on 1% LGT agarose gels and ligated to 
5 ng of Eco Rl-cleaved plasmid Bluescript KS+ (Stratagene).  Plasmid mini- 
preps were used as source of DNA for deriving nested deletion sets of  cDNA 
inserts by exonuclease IlI/mung bean nuclease treatment (Henikoff, 1984) 
and/or for primer or oligonucleotide directed dideoxy sequencing on dou- 
ble-stranded DNA by the method of Sanger et al. (1977).  Computer-aided 
analysis of DNA sequence information was performed using the Pustell pro- 
gram (IBI) or the series of programs published by the Genetics Computer 
Group (Madison, WI). 
Genomic Library Construction 
DNA segments of 12-15 kb from Mbo I partial digests were inserted into 
left and right arms of Barn HI-cleaved Mam phage DNA. This Aam Barn 
bacteriophage vector was constructed by substituting the 5.0-kb  cosL-Ava 
I segment of kCharon 4A phage DNA for the equivalent segment of MI 
DNA (Mullins et al.,  1984)  and selecting phage on su-/su  + hosts. A li- 
brary of >10  ~ independent recombinants was obtained after packaging the 
ligated hJam and transfectant DNAs in vitro and plating on Escherichia coil 
host LE392.  Positive phage were purified, DNAs were prepared, and re- 
striction segments were separated on 1% agarose gels before blotting on 
nitrocellulose membranes according to Southern (1975).  Appropriate seg- 
ments were subeloned into Bluescribe (-) or Bluescript KS+ or SK+ plas- 
raids for double-stranded DNA sequencing. 
Western Blot Analysis 
Peptide/N-glycanase was purified from culture supernatants of Flavobac- 
terium meningosepticum  by the method of Tarentino et al. (1985).  No en- 
doglycosidase F or endogenous protease activity could be demonstrated in 
this preparation. Transfectant 23.4 11+ or normal mouse L cells were lysed 
in phosphate buffer containing Triton X-100 (PBS-T;  10 mM NaPO4,  pH 
7.3,  140 mM NaCI,  10 mM EDTA,  10 mM benzamidine, 1 mM difluoro- 
phosphate, and 1% Triton X-100) by sonication at 4°C. Aliquots of lysate 
containing up to 100/xg of total protein were brought to 1% SDS and 1 mM 
/~-mercaptoethanol and heated to 100°C for 3 min. After cooling, the dena- 
tured lysates were mixed with an equal volume of 2 x  endo F  digestion 
buffer (Ix  =  0.2 M NaPO4, pH 8.7, 0.75%  NP-40,  5 mM EDTA, 5 mM 
o-phenanthrolene, and 0.5 mM PMSF). Peptide/N-glycanase (0.4 #g) was 
added and digestion was performed for 3 h at 37°C. An additional 0.1 #g 
of enzyme was added and digestion was continued for an additional hour. 
Controls for enzyme reactivity included the complete deglycosylation of an 
cq-acid glycoprotein. Reactions were terminated by the addition of 1/3 vol 
of4x SDS-PAGE sample buffer, then heated for 7 min at 100°C.  Digested 
samples were analyzed by SDS-PAGE 10-20%  gradient gels (Laemmli, 
1970).  Proteins were transferred to nitrocellulose by the method of Towbin 
et al. (1979).  Membranes were blocked for 1 h in PBS-T containing 5% 
BSA.  Rabbit anti-CEA  Ig  (DAKOPATTS,  Copenhagen,  Denmark)  was 
used at 2  #g/m_l and goat anti-rabbit Ig alkaline phosphatase conjugate 
(Promega Biotec, Madison, WI) was used at a dilution of 1:7,500. Detection 
was by incubation of the membrane in 100 mM Tris-HCl, pH 9.5,  100 mM 
NaCI, 5 mM MgCI2 containing 66 mg/ml of nitro blue tetrazolium and 33 
mg/ml of 5-bromo-4-chloro-3-indolyl phosphate. 
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Isolation of TM-CEA cDNAs 
Northern blot analysis was performed on poly A+  RNA 
from the L-cell transfectant line, 23.4  11+  that had been 
selected for the expression of CEA isoantigens (Kamarck et 
al.,  1987).  Use of the CEA partial cDNA insert, LV7, as 
probe identified multiple hybridizing RNA bands with ap- 
proximate molecular sizes of 3.9, 3.7, 2.2, and 1.8 kb (Fig. 
1, lane a). This pattern also recurs in the colon adenocarci- 
noma cell line HT-29 (Fig. 1, lane b), which in addition ex- 
presses mRNAs for CEA (4.0 and 3.6 kb) and NCA (3.0 kb) 
(Barnett et al.,  1988).  To clone the unidentified mRNAs, 
3-4-kb  double-stranded cDNA  from 23.4  11+  poly A+ 
RNA was size selected and inserted into Xgtl0. A library of 
8  x  10  ~ pfu was screened by LV7 hybridization. 13 phage 
were isolated, and the subcloned inserts from three of these, 
tc16-19 (3.6 kb), tc19-22 (3.5 kb), and tcE22 (3.3 kb), were 
analyzed by restriction endonuclease mapping. Insert tcE22 
differed from the others by an apparent internal deletion of 
,o 300 bp. Additional cDNAs were prepared from an HT-29 
cDNA library that was size selected in the 1-3-kb region. 
Based on the observation by Gold and Freedman (1965) 
that CEA is expressed during fetal development, we also 
screened.a cDNA library (2  ×  105 pfu; Clontech Laborato- 
ries Inc., Pale Alto, CA) prepared from normal human fetal 
liver poly A + RNA with the CEA probe, LVT. Five positive 
recombinant phage were isolated and the inserts were sub- 
cloned into plasmid vectors. Two overlapping inserts, cFIA 
and cFL5,  together comprised a  3.6-kb  fetal liver cDNA 
identical in restriction map to tc16-19  and tc19-22. 
Fig.  2  shows  the  compilation of DNA  sequences  and 
deduced amino acid sequences from the inserts of plasmids 
ptcl6-19, ptc19-22, ptcE22, pcFL4, and pcFLS. These in- 
serts  together  provided  the  longest  open  reading  frame 
(nucleotides 73 to 1656) and the longest cDNA (3464 nu- 
cleotides). The compiled sequence codes for an apoprotein 
of 526 amino acids (Mr of 58 kD) with 19 potential extra- 
cellular N-linked glycosylation sites (Asn-X-Thr/Ser). 
The coding sequence of the proposed apoprotein (desig- 
nated  TM1-CEA)  demonstrates  marked  similarity to  se- 
quences found in CEA and NCA cDNA clones. This is indi- 
l~gure  L  Expression of CEA-related 
poly A+ RNAs. One-tenth microgram 
of CEA-transfectant  23.4 11+ poly A+ 
RNA (lane a) and two micrograms  of  co- 
Ion carcinoma cell line HT-29 poly A+ 
RNAs (lane b) were subjected to elec- 
trophoresis on a 2.2 M formaldehyde- 
0.8% agarose gel, transferred to nylon 
membrane, and hybridized with 32p-la- 
beled LV7 DNA. 
cated by the proposed domain structure illustrated in Fig. 3 
and by the sequence relationships detailed in Table I. As is 
typical for other CEA isoantigens, the TM1-CEA polypep- 
tide initiates with a M-amino acid leader sequence that ends 
at  a  short  side-chain amino acid,  alanine.  The  proposed 
NH2-terminus of TM1-CEA contains glutamine as the first 
residue that initiates at  108-amino acid NH~-tenninal do- 
main. This domain is identical in length and highly similar 
in sequence to the comparable domain of CEA and NCA 
(Fig. 3 and Table I). This is followed by a disulfide-loop do- 
main (LD) that is a characteristic feature of CEA and is ,o178 
amino acids in length (Oikawa et al.,  1987). 
This domain differs from the single disulfide loop domains 
of immunoglobulins in that each one contains four cysteine 
residues capable of forming 47- and 39-amino acid disulfide- 
linked loops. Loop domains are repeated three times in CEA 
and once in NCA (Fig. 3).  The disulfide-loop domain size 
for TM1-CEA is similar to those of CEA and NCA, and the 
position of its cysteines is strictly conserved. In contrast to 
the domains of CEA and NCA, LD I of TM1-CEA has a fifth 
cysteine (residue 308; Fig. 2) that may not be involved in the 
formation of an intrachain disulfide loop. 
An interesting structural region follows the conserved 177 
amino acid loop-domain of TM1-CEA. This region, extend- 
ing from nucleotides 1,030 to 1,340, codes for ,el00 amino 
acids and has the appearance of a "half" disulfide-loop do- 
main (LD I/a of Fig. 3). This is indicated by comparison of 
amino acids that initiate loop domain regions in CEA, NCA, 
and TM1-CEA and by the characteristic positioning of its 
only two cysteine residues to form a 47-amino acid disulfide 
loop. While each of the disulfide-loop domains of the three 
CEA classes is highly conserved (,o70% amino acid similar- 
ity overall), LD IIa of TM1-CEA retains ~44 % amino acid 
similarity compared to TM1-CEA LD I (Table I). 
A 32-amino acid hydrophobic region comes after LD IIa 
and bears sequence similarity to the short hydrophobic tail 
that terminates CEA and NCA (Table  I).  Hydropathy plot 
analysis  supports  the  inference that this  is  a  membrane- 
spanning region (data not shown). By contrast, the carboxyl- 
terminal region of TM1-CEA is composed of a hydrophilic 
stretch of 71 amino acids that terminates at residue 526 (nu- 
cleotide 1667). 
Identification of TM-CEA cDNAs Derived  from 
Alternatively Spliced mRNAs 
Four different  molecular sizes of CEA-related rnRNA are de- 
tected in transfectant cell line 23.4 11+ and are observed in 
tumor cell line HT-29  (Fig.  1). Additional cDNAs isolated 
from 23.4  11+  and HT-29 cDNA libraries established that 
the observed mRNA species are derived by alternative RNA 
splicing. 
DNA Sequence of TM2-CEA. Insert tcE22, isolated from 
the 23.4 11+ eDNA library, presented a restriction map in- 
distinguishable from TM1-CEA clones when a 300-bp gap 
was positioned within the molecule. DNA sequence analysis 
showed that tcE22  codes for a  second TM-CEA  species 
(TM2-CEA), which is identical to the TM1-CEA apoprotein 
with the exception of a 100-amino acid gap that corresponds 
exactly to LD IIa (Figs.  2  and 3).  We conclude that this 
cDNA accounts for the 3.7-kb mRNA observed in Fig. 1 and 
that it is derived by alternate splicing of the transcript that 
Barnett et al. Transmembrane Carcinoembryonic  Antigens  269 CAG CCG TGC TCG /tAG CGT TCC TGG AGC CCA AGC TCT CCT CCA CAG GTG AAG ACA GGG CCA GCA GGA GAC ACC  72 
ATG GGG CAC CTC TCA GCC CCA CTT CAC RGA ~"~G CGT GTA CCC TGG CAG GGG CTT CTG CTC /~:A GCC TCA CTT  144 
Met Gly fill  Leu Ser Ala Pro Leu llls  Alrg VIII  Ar~ Vail Pro Trp Gln Gly Leu Leu Lmu Thr Ala Set Leu  24 
-34 
CTA ACC TTC TGG A~tC CCG CCC ACC ACT GCC CAG CTC ACT ~T  GAA TCC ATG (:CA TTC AAT GTT GCA GAG GGG  216 
Le~ Thl~ Pho Trp /tin Pro  Pro  Thr Thr J%la  ~In Leu  Thr Thr G1u Self  Met Pro Phe /uln Val Ala GIU Gly  48 
-I  +1 
AAG  GAG  GTT  CTT  CTC  CTT  GTC  CAC  ART  CTG  CCC  CAG  CAR, CTT  TTT  GGC  TAC  AGC  ~  TAC  AAA  GQG  GAA AGA  2118 
Lyl Olu Val Leu Leu Leu Val His Aln Leu Pro Gln Gin l~u Ph~ Gly Tyr Set Trp Tyr Lya GIg GIU Ar  0  72 
GTG GAT GGC AAC CGT CAA ATT GTA GGA TAT GCA ATA GGA ACT CAA CAA GCT ACC CCA GGG CCC GCA AA~ ~  360 
Val Alp G1y A~n Ar~ Gln  lle Vail GIy Tyr Ala  IIi Gly Thr Gln Gin &la Thr ~ro Gly Pro AI~ Ash Sot  96 
GGT CGA GAG ACA ATA TAC CCC AAT GCA TCC CTG CTG ATC CAG AAC GTC ACC CAG AAT GAC ACA GGA TTC  TAC  432 
Gly Arg Glu Thr  lle Tyr Pro Asn Ala Set Leu Leu  11o Gln ASh Val Thr Gln Aln Alp Thlt Gly Ph~ Tyr  120 
ACC CTA CAA GTC ATA AAG TCA GAT CTT GTG /tAT  GAA GAA ~A  ACT GGA CAG TTC CAT GTA TAC CCC~  GAG CTG  504 
ThE Leu Gln Val  lle Lys Set Asp Leu Vall ASh GIu Glu Ala Thr Gly Gln Phe B£S Val Tyr ProL~  1~u  144 
CCC AAG CCC TCC ATC TCC AGC AAC AAC TCC AAC CCT GTG GAG GAC AAG GAT GCT GTG GCC TTC ACC TGT GAA  576 
Pro Lys Pro Sot  lle Set Ser ASh Aln Ser Aln Pro Val ~lu Amp Lys A~p Ala Val Ala Phe Thr Cys Glu  168 
CCT GAG ACT CAG GAC ACA ACC TAC CTG TGG TGG ATA AAC AAT CAG AGC CTC CCG GTC A~T CCC AGG CTG CAG  648 
Pro GIu Thr Gln Asp Thr ThE Tyr l~u Trp Trp  Ile A~n Ash Gln $1elr  L~u Pro Vltl Set Pro Arg Leu Gln  192 
CTG  TCC /tAT GGC AAC AGG ACC CTC ACT CTA CTC AGT GTC ~A  AGG /tAT GAC ACA GGA CCC TAT GAG TGT GAA  720 
Le~ Sot R~In Gly Ash AJr~ Thr Leu Thr Leu Leu Set Val Thr Ac~l Aln Asp Thr Gly P~o Tyr Glu Cy~ Glu  216 
ATA CAG AAC CCA GTG AGT GCG AAC CGC AGT GAC CCA GTC ACC TTG AAT GTC ACC TAT GGC COG GAC ACC CCC  792 
Ile Gln Ash Pro Val Set Ala Amn Al:g Set A~p Pro Val Thr Leu ASh V&I Thr Tyr Gly Pro Asp Thr Pro  240 
ACC ATT TCC CCT TCA GAC ACC TAT TAC CGT CCA GGG GCA AAC CTC AGC CTC TCC TGC TAT GCA GCC TCT AAC  864 
Thr  Ilm Set Pro Set Amp Thr Tyr Tyr Al:g Pro Gly Ala Asn Leu Set Leu  ~eJr  cy. Tyr Ala A1a Sot ASh  264 
CCA CCT GCA CA~ TAC TCC TGG CTT ATC AAT GGA ACA TTC CAG CAA AGC ACA CAA GAG CTC TTT ATC CCT AAC  936 
Pro Pro Ala GII~ Tyr Sot Trp Leu  lie ASh Gly Thr Phe Gin Gin Ser Thl: Gln Glu l~u Phe  Iio Pro A~n  25~ 
i 
ATC ACT GTG AAT AAT AGT GGA TCC TAT ACC TGC CAC GCC /tAT AAC TCA GTC ACT GGC ~w_C AAC /~G ~C  ACA  1008 
Ile Thr Val Ash ASh Set Gly set Tyl: Thr Cys  llis  Ala ~uln  Aln Sot Viii Thr Gly  ~  A~n Arg Thr Thr  312 
.........  A 
GTC ~  ACG ATC ATA GTC ACT G~  CTA ~  (:CA GTA GTA GCA AAG CCC CAA ATC AAA GCC AGC AAG ACC ACAiI080 
Val Lys Thr  II~  Ile Val Th~GIU  Leu Slur  Pro Val Val Ala Lyll Pro Gln  Ile Lys Ala Set Lys Thr Thr  336 
I~TC l~& GG& CAT AAG GAC TCT GTG J~AC CTG ACC TGC TCC ~A  AAT GAC ~T  GG& &TC T~C &TC COT T~G TTCllI52 
Val 'Fnr  Gly AS  I) 5ys Amp  Sez Val Ash Leu Thr C~l  ~  ~r  Thr ASh  AS])  Thr Oly  Iio S~r  lle Ar~ Trp Phle  360 
[T~.C AJ~A AAC tAG ~GT CTC CCG TCC TCG GAG AGG ATG AAG CTG TCC CAG GGC AAC ACC ACC CTC AGC ATA AAC~1224 
Phe Lys Ash GI~ Set Leu Pro Ser Set Glu Arg 14~ Lye 1~u Sot Gln ~ly Aln Thr Thr Leu Sot  Ile Aln  384 
~T  GTC 
Pro Val 
I~e A're 
PrO  lie 
AJ~G ~  GAG CAT GeT GGG ACG TAT TGG TGT GAG GTC TTC AAC CCA ATC AGT ~  AAC CAA AGC GAC  |296 
Ly~ AZg GIu AJIp Ala Gly Thr Tyr Trp CI~ G1u Val Phe Aln ~ro  11o sot Ly~ Ash Gln Set i~Ip  408 
i  sp  ......... 
ATG CT~ AAC GT& RAC ~%T AAT GCT CTA CCA C2kA GAA AAT GGC CTC TCA CCT GGG GCC ATT GCT GGC  1365 
14m~ Leu Aln Vail Aln Tyr A~n Ala Le~ Pro Gln Glu /uln  ~.~.~.~.~.~.~.~.~.GI  Leu Star Pro  G1  Ala  Ile Ala G1  432 
ATT GTG ATT GGA GTA GTG GCC CTG GTT GCT CTG ATA GCA GTA C.CC  CTG ~CA TGT TTT CTG CAT TTC G~G AAG 
lle V&I  Ilo G1  Val Vail Ala LeU Val Ala 1.4tu Ile Alto Vail Ala Leu Ala C  I  phle Leu Hin Phe G1  Lys 
......  So  r$ llrG lyP roL 
Thr Gly Arg 2%111  Set Alp Gin Alr~l  Alp Leu Thr GIU H£B Lys Pro Sot Val Set Ash  HI1 Thr Gin Aap Big  480 
OUG in*  ** 
TCC RAT GAC CCA CCT AAC AA~ ATG AAT GAA GTT ACT TAT TCT ~C  CTG AAC TTT GAA GCC CAG CAA CCC ACA 1584 
Set Alln Alp Pro Pro /kln Lya Plet ASh Glu Val Thr Tyr Set Thr Leu Asn Phll  Glu Ala Gln Gln Pro Thr  504 
00°0~ 
.,::.....:h, 
CAA CCA ACT TCA GCC TCC CCA TCC CTA AC2% GCC ACA GAA ATA ATT TAT TCA GAA GTA AAA AAG CAG TAA TGA 1656 
Gln Pro Thr Set Ala Set Pro $or Leu Thr Ala Thr Glu  Ile  lie Tyr Set Glu Val Lye Lys Gin  ***  ***  526 
AAC CTG TCC TGC TCA CTG CA~ TC.C  TGA TGT ATT TCA AGT CTC TCA CCC TCA TCA CTA GGA GAT TCC TTT CCC 
CTC TAG GGT AGA GGG GTG GG~ ACA GAA ACA ACT TTC TCC TAC TCT TCC TTC CTA ATA GGC ATC TCC J~;G CTG 
COT GGT CAC TGC CCC TCT CTC AGT GTC AAT AGA TGA AAG TAC ATT GGG AGT CTG TAG GAA ACC CAA CCT TCT 
T~T CAT TGA AAT TTG GCA ~  CTG ACT TI~ GGA AAG AGG GAC CAG AAC TTC CCC TCC CTT CCC CTT TTC CCA 
ACC TGG ACT TI~T TT? AAA CTT GCC TGT TC&  GAG  CAC  TCA TTC CTT CCC ACC CCC AGT CCT GTC CTA TCA CTC 
TAA TTC GGA TTT GCC ATA GCC TTG AGG TTA TGT CCT TTT CCA TTA AGT ACA TGT G~C AGO AAA CAG CGA GAG 
AGA GRA AQT AAA CGG CAG TAA TGC TTC TCC TAT TTC TCC AAA GCC TTG TG? GAA CTA ~A  A~G /~A AGA AAA 
CCA JkAT A?A TAA CCA ATA GTG ARA TGC CAC AGG TTT GTC C.AC TGT CAG GGT TGT CTA CCT GTA GGA TCA GGG 
TCT AAG CAC CTT GGT OCT TA~ CTA GAA TAC CAC CTA ATC CTT CTG GCA AGC CTG TCT TCA GAG AlkC CCA CTA 
GAA GCA ACT AQG AAA AAT CAC TTG CCA ~  TCC AAG GCA ATT CCT GAT GGA AAA ~  AAA AGC J~A TAT ATG 
TTT TAlk TAT CTT TAT GGG CTC TGT TCA AGG C.AG TGC TGA GAG GGA ~G  GTT ATA ~T  TCA GGA GGG AAC CAG 
CTT CTG ATA AAC ACA A?C TGC TAG GAA CTT GCeG AAA GGA ATC AGA GAG CTG  CCC TTC 2~;C CAT TAT T/A RAT 
TAT TGT TAA A~A ATA CAC AAT TTG GGG TAT TGG GAT TTT TCT CCT TTT CTC TCeA GAC ATT CCA CCA TTT TAA 
TTT TTG TAA CTG  CTT ATT TAT GTG  A&A AGG  ~T  ATT TTT ACT TAG CTT A~C TAT GTC AGC CAA TCC G~T TGC 
CTT ~  TGA AAG AJ~A CCA CCG AAA TCC CTC IL~-.G  TCC CTT GGT CAG GAG CCT CTC AAG ATT TTT ~T  GTC AGA 
GGC TCC AAA TAG AAA ATA AGA ~  GGT TTT CTT CAT TCA TGG CT& GAG CTA CAT TTA ACT CAG TTT CTA GGC 
~CC TeA GAC C~A TeA TCA ACT ACC ATT CTA TTC CAT G~T TGC ACe T~T GCA TTT TCT ~TT TGC CCC CAT TCA 
CTT TQT CAG GAA R~C TTG GCC TCT GCT ~  GTG TAT T'EG GTC CTT GAG AAG TQG GAG CAC ~T  ACA G~G ACA 
CTA TCA CTC ATG CTG GTG GCA TTG TTT ACA GCT AGA AJ~E CTG CAC TC.G TC.C TAA TC.C CCC TTG GQA I%AT GGG 
GCT GTG ~  A~  AGG ATT ATA ACT TAG GCC TJt~ C~T ~'TT TTA ACA GCC  TCT GAA ATT TAT CTT TTC TTC TAT 
GGG GCT TAT /k%A ~T  AT(: TTA T~A TAA ~AA GGA AGG ACA GGA GGA AGA CAG GCA AAT ~TA CTT CTC ~C  CAG 
TCT T~T ACA CA~ ATG GA~ TCT CTT TGG GQ(2 TAA GAG AAA ~T  TTT ATT CTA TAT TGC TTA CeT GAT CTC ATG 
TTA GCeC CTA ~A  GGC TTT CTC ~  GAQ C~AT  TAG CTT ~  GTT CTC TAT ACT C2k~ GTA OCT CTT TCA ~  TTT 
TCT AAC CCT GAC i%CG GAC TGT GCA TJ~ TTT CCC TCA TCC ATG CTG TGC TGT GTT ATT TAA TTT TTC CTG GCT 
A~G ATC ATG TCT GAA TTA TGT ATG AAA ATT ATT CTA TGT TTT TAT AAT AAA AAT AAT ATA TCA GAC ATC GAA 
AAA AAA AA  :1464 
N/ 
1440 
456 
Figure 2. DNA and deduced amino acid sequences 
of TM-CEA cDNAs. The DNA sequences were 
compiled from double-strand  didcoxy termina- 
tion reactions on both strands of all clones. The 
full sequence from nucleotide 1 to 3,464 corre- 
sponds to TM1-CEA.  The initiating methionine 
residue of the apoprotein is at position -34 rela- 
tive to the proposed  amino terminus of the ma- 
ture protein at +1. Symbols ~  J  demarcate the 
likely beginning and end of the first loop-domain 
based on similarity with CEA and NCA; solid 
bars note consensus sequences for N-linked gly- 
cosylation sites;  •  are cysteine residues  in the 
extracellular  portion of the molccule;~is  the 
only unpaired cysteine residue in the extracellu- 
lar region;  the thick barberpole  line indicates  a 
hydrophobic  transmembrane  region.  The open 
box around nucleic acid sequence corresponds to 
the "half  ~ loop-domain (LD IIa) region deleted in 
TM2-CEA; the single amino acid that is altered 
as a result of "half' loop-domain deletion, i.e., 
aspartic aci  0  (Asp),  is shown as a split residue 
above the corresponding  split cndon in the TM1- 
CEA sequence; dots  on either side of the Asp 
residue indicate that all adjacent sequences are as 
shown for TM1-CEA.  The 53  nueleotides that 
are deleted in the cytoplasmic region of TM3- 
CEA are indicated by the shaded portion of the 
broken box. The new amino acid, serine (Ser), 
that is generated at the splice junction, and sub- 
sequent new amino acids that are translated by 
the induced frameshift,  are shown above  their 
corresponding  new codons; dots amino-terminal 
to Ser indicate that all sequence to that point is 
identical to TM1-CEA.  Termination of transla- 
tion is indicated by • **. Solid and broken trian- 
gles show potential  polyadenylation signals for 
TM1/TM2-CEA  and  for  TM3-CEA,  respec- 
tively; the up arrow after nucleotide 1,662 indi- 
cates the presence of a short oligo A stretch de- 
tected  in the TM3-CEA cDNA. 
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Figure 3. Schematic representation of  proposed structural 
domains  of CEA-isoantigens  TM1-CEA, TM2-CEA, 
TM3-CEA, TM4-CEA, and their comparison with CEA 
(180 kD) and NCA. Thin lines correspond to the 5' and 
3'  untranslated  regions. The  coding  regions  of the 
apoproteins (rectangle) initiate with ATG and are divided 
into leader sequences (I), NH2-terminal sequences (J), 
loop-domains ([]), hydrophobic regions (n), and a cyto- 
plasmic  region for TM-CEA  (m). TAG and TAA are 
translation stop codons. Lines connecting structural do- 
mains indicate where the TM-CEA  apoproteins differ 
from TM1-CEA. The symbol  I indicates the segment 
resulting from the translational frame shift in TM3- and 
TM4-CEA (see text for details). A, is poly A. 
also generates TM1-CEA. The predicted apoprotein size of 
TM2-CEA is 47 kD. 
DNA Sequence of TM3-CEA.  Northern analysis of poly 
A+ RNAs indicated a prominent 2.2-kb RNA species when 
hybridized with LV7 probe DNA (Fig.  1). cDNA from HT- 
29 poly A+  RNA yielded two partial clones that could be 
distinguished from TM1- and TM2-CEA cDNAs by restric- 
tion site analysis.  Efforts to isolate full-length versions of 
TM3-CEA cDNA from the 23.4 11+  library were not suc- 
Table L Amino Acid Sequence Identities 
among CEA Family Members 
Regions compared (in percent) 
Members 
compared  Leader  NHE-terminal  Loop-domain  HR 
NCA/CEA  73  89  85  (CEA I)  76 
77  (CEA II) 
76 (CEA III) 
CEA/TMI-CEA  76  87  83  (CEA 1)  67 
79  (CEA II) 
73 (CEA III) 
NCA/TM 1-CEA  76 
TM 1  -CEA: 
domain I  vs.  IIa  - 
89  86  62 
44 
For each comparison, the different  regions correspond to signal  sequences 
(amino  acids -34--1),  NH2-terminal segments (amino acids 1-I08),  loop- 
domains (amino acids 109-286,  287--464, and 465-642 for CEA, and 109-286 
for NCA [Barnett et al., 1988], 109-285 and 286-389 for loop-domains I and 
lla, respectively, of TM-CEA), and hydrophobic regions (HR) (amino acids 
643-668 for CEA, 287-310 for NCA, and 390-421  for TM-CEA). Sequence 
comparisons are strictly on the basis of amino acid identity; conservative sub- 
stitutions  have  not been permitted.  Where one region is  slightly  different 
in length  from its counterpart, percent identity  is calculated  on the shorter 
sequence. 
cessful. The DNA sequence of these partial cDNAs corre- 
sponds exactly to nucleotides 345-1,448 and 1,502-1,662 of 
TM1-CEA cDNA.  The deletion of 53 bp between nucleo- 
tides 1448 and 1502 occurs in the DNA coding for the cyto- 
plasmic region (shaded box of Fig. 2). As 53 bp is not a mul- 
tiple of a codon triplet, nucleotides after 1,448 yield a new 
translation reading frame and generate a  new cytoplasmic 
component for TM3-CEA (schematically drawn in Fig. 3). 
The sequence indicates a translation of six new amino acids, 
followed by a TGA stop codon (nucleotide 1518). This results 
in a 9-amino acid cytoplasmic region for TM3-CEA com- 
pared to a 71-amino acid region for TM1- and TM2-CEA 
producing an apoprotein of 51 kD. A potential polyadenyla- 
tion consensus sequence AATAAT (Wickens and Stephen- 
son, 1984) in the 3' untranslated region (UTR) of TM3-CEA 
mRNA is found at a position that precedes a short run of 
oligo A nucleotides where the sequence diverges from that 
of TM1- and TM2-CEA. The likely polyadenylation site oc- 
curs in sequence that codes for the TM1- and TM2-CEA cy- 
toplasmic domain. 
DNA Sequence of TM4-CEA.  Although we have yet to 
obtain a representative cloned cDNA sequence, we speculate 
that there exists an additional  TM-CEA molecule, TM4- 
CEA (calculated Mr of 40 kD), in which both LD Ha and 
the cytoplasmic region are alternatively spliced as in TM2- 
CEA and TM3-CEA, respectively (illustrated in Fig. 3). Ex- 
perimental support for a fourth TM-CEA molecule comes 
from our observation of a 1.8 kb mRNA that is observed in 
Northern blots of 23.4 11+ cell mRNA (Fig. 1, lane a). The 
estimated size of TM4-CEA mRNA without a poly A ÷ tail 
is  1.4 kb.  As our size estimates for each of the TM-CEA 
RNAs  by  Northern blot  analysis  is  consistently 300--400 
bases longer than that of the cDNA, it is likely that the 1.8-kb 
RNA codes for TM4-CEA. 
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of CEA-related poly A+  RNA. 
Two  micrograms  of  poly  A+ 
RNAs  from  various  tumor  cell 
lines  were  subjected to electro- 
phoresis on a  2.2  M  formalde- 
hyde-0.8%  agarose  gel,  trans- 
ferred  to nylon membrane,  and 
hybridized with 32p-labeled  CY'IO 
probe DNA ([.4] lane a, SW403; 
lane  b,  LoVo; lane  c,  DLD-I; 
lane d, HT-29; lane e, KG-I; lane 
f, BeWo; lane g,  SCaBER; and 
lane  h,  MIA  PaCa-2) or  LV7 
DNA ([B];  for lanes c, d, f, g, 
and h; CYTO and LV7 patterns 
are identical).  Autoradiographic 
exposures have been adjusted to 
accommodate the  differences in 
TM-CEA  mRNA concentration 
displayed  by the cell lines SCaBER 
and MIA PaCa-2. 
Expression of TM-CEA cDNAs 
To investigate the specific expression of TM-CEA mRNAs 
in tumor cells of different origins, we probed cellular RNAs 
with a cDNA probe derived from the cytoplasmic region of 
the  TMI-CEA  cDNA  (CYTO  probe;  nucleotides  1,443- 
1,676). Fig. 4 A shows hybridization of the CYTO probe to 
poly A+ RNAs from a variety of tumor cell lines (lanes a-h). 
All of the tumor cell lines shown,  representing colorectal 
adenocarcinomas (SW403, lane a; LoVo, lane b; DLD-1, lane 
c; HT-29, lane d), acute myelogenous leukemia (KG-1, lane 
e), choriocarcinoma (BeWo, lane f), squamous bladder ade- 
nocarcinoma (SCaBER, lane g), and pancreatic adenocarci- 
noma (MIA PaCa-2, lane h) express the TM-CEA mRNAs. 
While some of these tumors express other CEA-isoantigen 
mRNAs  based on hybridization to LV7 cDNA (Fig.  4  B, 
lanes a, b, and e), BeWo, SCaBER, and MIA PaCa-2 express 
only the transmembrane CEA isoantigen mRNAs (data not 
shown). 
The Complete Transcription Unit of TM-CEA 
We have reported the transfection of the TM-CEA transcrip- 
tion  unit  into primary  and  secondary L-cell transfectants 
(Kamarck et al.,  1987). To clone genomic segments corre- 
sponding  to  this  transcription  unit,  a  hJam  recombinant 
DNA  library  of 2  ×  106  independently  derived  recom- 
binants were obtained from an Mbo I partial digest of trans- 
fectant cell 23.4  11+  DNA.  96 phage that hybridized with 
radiolabeled human DNA were plaque purified and a num- 
ber of these phage isolates (M1, X22, and ),39) also hybrid- 
ized with the LV7 probe. DNA inserts of these three phage 
ranged in size from 12 to 20 kb and contained the 5.3-kb Barn 
HI restriction segment shared by all of the primary and sec- 
ondary L-cell transfectants (Kamarck et al.,  1987). 
Defined restriction fragments of TM1-CEA cDNA were 
subcloned for analysis of the genomic DNA.  A 5' untrans- 
lated region probe (cDNA nucleotides 0-72) hybridized to 
genomic phage M1, X22, and ~39. A 3' UTR probe (3'UTR3; 
A 
B 
C 
0  2  4  6  8  10  12  14  16  18 
I  I  I  I  I  I  I  I  I  I 
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k55 
"  I  I  x  II  I  ;;1  o.  . 
II  I  I 
Bg  BO  Bg  Bg 
I  I  m 
5'UTR/  LD I  LD Ila 
L-NH 2 
20  22  24  26  28  30  32  34 
I  I  I  I  I  I  I  I 
;L39 
Zll 
~.47 
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Figure 5. Map of TM-CEA genomic 
DNA. (A) Extent of human genomic 
DNA  contained  in  each  X phage 
selected from the transfectant cell li- 
brary.  Dots indicate that the phage 
insert  extends beyond that  shown. 
(B) Composite restriction map con- 
tained  in  the  five ~,  phage  shown 
above. Symbols are: R, Eco RI; B, 
Barn HI; Bg, Bgl II; H, Hind III; and 
X, Xho I. (C) Restriction segments 
of  genomic  DNA  homologous  to 
subcloned portions of eDNA repre- 
senting  structural  domains  in  the 
apoprotein. These segments are de- 
scribed in the text. 
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phage, but did identify two additional human recombinant 
phage (3`47 and 3,55) derived from the transfectant genomic 
library. Restriction site mapping demonstrated that all of the 
identified phage overlapped (Fig. 5, A and B). Localization 
of the 5' and 3' UTR to genomic restriction segments indi- 
cated that the cDNA coding sequence is contained within 
•23  kb of genomic DNA (Fig. 5, B and C). 
cDNA  restriction segments defining structural domains 
within TM-CEA apoprotein were used to determine their lo- 
cation within genomic DNA (Fig. 5 C). For example, cDNA 
sequences coding for the LD IIa structural domain (eDNA 
nucleotides  1017-1343;  Fig.  2)  were localized to a  3.8-kb 
Hind III genomic segment (Fig. 5 C). In a similar manner, 
coding sequences for the leader and NH2,terminal domains 
(L-NH2),  the first disulfide-loop domain (LD I), the trans- 
membrane domain (TM), and cytoplasmic domains (CYT1 
and CYT2) were localized to genomic restriction segments 
(Fig. 5 C). 
To look for other genomic sequences related to the TM- 
CEA  cytoplasmic domain,  the  CYTO  probe  (nucleotides 
1,443-1,676)  was hybridized to a  Southern blot of human 
genomic DNA cleaved with several restriction endonucleases. 
In contrast to the complex pattern obtained at high stringency 
with the domain probe LV7 (Kamarck et al., 1987), hybrid- 
ization performed even at reduced stringency (60°C;  6× 
SSPE) produced one band per lane indicating that there is 
a single cytoplasmic region in the genome (data not shown). 
Delineation of  Exon-Intron Boundaries 
To support the evidence for alternative RNA splicing, we se- 
quenced selected exon boundaries of the TM-CEA genomic 
DNA. For example, the 3' end of LD I was sequenced from 
a subclone of the 2.5-kb Bgl II genomic segment (Fig. 5 B) 
that hybridizes with the loop-domain probe,  LV7. Double- 
stranded DNA sequencing using the dideoxy chain termina- 
tion method was performed after extending an oligonucleo- 
tide primer from the 3' end of LD I, in this example, into 
adjacent intron sequence. A summary of selected exon-in- 
tron junction sequences is presented in Table II. Our data 
demonstrate that the structural domains defined as LD IIa, 
transmembrane, and cytoplasmic regions are coded for by 
discrete exons flanked by splice donor-acceptor sites. In ad- 
dition, the nucleotide sequences of the exon-intron bound- 
aries confirm the proposed location of  junctions for alterna- 
tive splicing based on the cDNA sequences of TM1- through 
TM4-CEA. 
Biochemical Analysis of TM-CEA Isoantigens 
Western  immunoblot  analyses,  using  a  broadly  reactive 
anti-CEA polyclonal antibody on lysates of 23.4 11+ cells, 
showed a complex array of antigens with molecular masses 
ranging from 50 to 150 kD (Fig. 6, lane A). This result is 
consistent with the existence of multiple TM-CEA isoanti- 
gens displaying extensive N-linked glycosylation. To assess 
the number of  different  TM-CEA apoprotein species actually 
present, we subjected 23.4  11+ polypeptides to enzymatic 
deglycosylation with peptide/N-glycanase isolated from F. 
meningosepticum (Tarentino et al., 1985).  As shown in Fig. 
6, lane B, western analysis of deglycosylated  transfectant cell 
proteins  demonstrates the  presence  of four to  five CEA 
isoantigen apoproteins. In contrast a lysate of control L cells 
shows no reactive species (Fig. 6, lane C). The mobilities 
of the major bands in lane B are consistent with the molecu- 
lar sizes of apoproteins calculated from translation of eDNA 
sequences: TM1, 58 kD; TM2, 47 kD; TM3, 51 kD; TM4, 
40 kD. The presence of an apparent doublet for the smallest 
species is presently not explained, but may be due to inacces- 
sibility of some N-linked oligosaccharides to enzyme. 
Discussion 
In the past 20 yr, an array of 8-10 CEA-related glycoproteins 
has been identified by biochemical methods in a variety of 
tumor and nontumor cells (for review see Shively and Beatty, 
1985).  Recently, the genes for two members of this isoanti- 
gen family, CEA and NCA, have been cloned (Beauchemin 
et al., 1987; Oikawa et al., 1987; Barnett et al., 1988; Neu- 
maier et al., 1988; Tawaragi et al., 1988). In this study, we 
identify mRNAs, cDNAs, and a genomic transcription unit 
that encode novel CEA isoantigen members with transmem- 
brane and cytoplasmic domains (TM-CEAs). Immunologi- 
cal data confirm that TM-CEAs are expressed at the cell sur- 
face. Although we cannot assign TM-CEA glycoproteins to 
previously identified CEA isoantigens (Shively and Beatty, 
1985),  on the basis of molecular size we suggest that TM1- 
CEA may be related to the so-called "128K antigen" (Neu- 
maier et al.,  1985). 
We have shown that an L-cell secondary transfectant, 23.4 
11+, and a number of tumor cell lines express a set of four 
RNA transcripts (3.9, 3.7, 2.2, and 1.8 kb) that are unrelated 
to CEA (4.0 and 3.6 kb) or NCA (3.0 kb) poly A+ RNAs. 
As the secondary transfectants likely contain a single geno- 
mic transcription unit, we proposed that these mRNAs rep- 
resented the products of alternative RNA splicing (Kamarck 
Table II. DNA Sequence at Exon-lntron Junctions of TM-CEA Genomic DNA 
Junction  Donor  Acceptor 
LD I-LD  IIa  .  .  .  GTC  ACT  G  gtaag ......  gacag AG CTA  AGT... 
1030  1031 
LD IIa-TM  .  .  .  GTA  AAC  T  gtaag ......  gacag AT AAT  GCT... 
1318  1319 
TM-CYT1  .  .  .  ACC  GGC  AG gtatg  ......  tttag G  GCA  AGC  .  .  . 
1448  1449 
CYTI-CYT2  .  .  .  AAC  CAC  A  gtaag ......  ag CT CAG  GAC... 
1501  1502 
Appropriate genomic restriction segments were subjected to DNA sequencing near the regions that are deleted or altered by splicing in TM2- and TM3-CEA 
cDNAs. Capitalized letters represent sequences contained in cDNA and genomic DNA, and adjacent small type represents intron sequence. Numbers refer to their 
positions in TMI-CEA eDNA. Abbreviations describing the exons are as defined in the text. 
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tigens  expressed  by  23.4 11+ 
transfectants. After transfer from 
gels, CEA isoantigens were de- 
tected using DAKO  anti-CEA Ig 
followed  by goat anti-rabbit alka- 
line phosphatase. (Lane A) Lysate 
from 23.4 11+ cells; (lane B)en- 
zymatically deglycosylated  lysate 
from 23.4 11+ cells; and (lane C) 
lysate from mouse L cells. Num- 
bers on the left indicate  the appar- 
ent molecular masses in kilodal- 
tons of  prestained  molecular  mass 
markers phosphorylase B (106), 
BSA (68),  ovalbumin (45),  and 
tx-chymotrypsin  (23). 
et al.,  1987).  The cDNA sequences of the TM-CEAs re- 
ported here, coupled with genomic DNA sequences at exon- 
intron  junctions, demonstrate that the mRNAs are indeed de- 
rived by alternative splicing from a single transcript. While 
TM1-CEA represents the largest transmembrane molecule, 
TM2-CEA lacks LD IIa, and TM3-CEA is defined by an al- 
ternate splice within the cytoplasmic domain, resulting in a 
unique intraceUular peptide sequence. The existence of an 
mRNA that contains both alternate splices, TM4-CEA,  is 
supported by expression in the transfectants of a 1.8-kb poly 
A+ RNA (Fig.  1, lane a) and a 40-kD apoprotein (Fig. 6). 
We also have cloned, as overlapping recombinant phage, 
the complete TM-CEA transcription unit which is encoded 
in  ~23  kb of genomic DNA.  Hybridization with cDNA 
probes indicates that structural domains defined by compari- 
son with other CEA-related genes correspond to discrete 
exons (Fig. 5). This was confirmed by the demonstration that 
regions adjacent to predicted exons are not found in cDNA 
and have consensus splice donor-acceptor sequences (Table 
II). These exon-intron junctions correspond exactly to the 
points of difference detected in the sequences of the alterna- 
tively spliced TM-CEAs. 
Cell lines derived from colorectal tumors primarily pro- 
duce CEA poly A+ RNA (Barnett et al., 1988),  consistent 
with their secretion of 180-kD  CEA. Using specific cDNA 
probes  we have demonstrated that TM-CEAs are also ex- 
pressed by a number of these colorectal lines, in addition to 
other tumor types. In some cell lines, only the set of TM- 
CEA mRNAs are expressed (e.g., BeWo; Fig. 4,  lane f), 
while in others, numerous CEA-related RNAs are addition- 
ally produced (e.g., HT-29;  Fig. 1, lane b). The expression 
of TM-CEAs is evidently not restricted to neoplastic tissue 
as TM1-CEA cDNAs have been cloned from an apparently 
normal fetal liver cDNA library. We cannot as yet correlate 
the expression of one or more CEA isoantigens with biologi- 
cal  function, cellular morphology, substrate adhesion, or 
metastatic potential. 
Members of the CEA isoantigen family display consider- 
able nucleotide and amino acid sequence conservation (Table 
I). With the exception of the "half" disulfide loop-domain of 
TM1-CEA,  all  of the  proposed  extracellular regions  are 
1>70% similar at the amino acid level and >t80% similar at 
the nucleotide level. This explains the ability of the TM- 
CEAs to be detected by several anti-CEA monoclonal anti- 
bodies  and also  illustrates the general cross-reactivity of 
anti-CEA immunoreagents. 
Extracellular loop domains in CEA isoantigens demon- 
strate  conserved  amino  acids  surrounding  the  cysteine 
residues that are reminiscent of immunoglobulins and immu- 
noglobulin  superfamily proteins  (HunkapiUer  and  Hood, 
1986). We have noted previously (Barnett et al., 1988),  and 
also  observe  here,  the  overall  structural  and  amino acid 
similarity of  all CEA glycoproteins to members of  the immu- 
noglobulin gene superfamily (Williams and Barclay,  1988). 
This-family extends to  cell  surface  recognition  proteins 
(Thy-1 ]Williams and Gagnon, 1982]), cell adhesion proteins 
(neural cell adhesion molecule [N-CAM;  Cunningham et 
al., 1987], ICAM [Simmons et al., 1988], T cell erythrocyte 
receptor CD2 [Peterson and Seed, 1987], and S- and L-MAG 
[Salzer et al., 1987; Arquint et al., 1987]), receptor proteins 
(T4  receptor  [Maddon  et  al.,  1985] and  PDGF  receptor 
[Yarden et al., 1986]), and oncogenes (CSF-1 receptor/v-fms 
[Hampe et al.,  1984]).  Although their ligands have not yet 
been  identified, we propose  by analogy that members  of 
the CEA isoantigen family act as cell surface recognition 
proteins. 
This analogy can be extended to the alternative structural 
forms of neural cell adhesion molecule (N-CAM) and myelin- 
associated  glycoprotein (MAG).  Three  different N-CAM 
isoantigens are generated from a  single genomic segment 
(Cunningham et al., 1987): the ssd form, with a short hydro- 
phobic COOH-terminus (like CEA and NCA), the sd form, 
with a short cytoplasmic domain (like TM3/4-CEA), and the 
/d form, with a longer cytoplasmic domain (TM1/2-CEA). 
Two cytoplasmic forms of MAG (S-MAG and L-MAG) have 
also been described (SaLzer  et al., 1987). For MAG, N-CAM, 
and TM-CEA, the alternative cytoplasmic regions are de- 
rived by differential splicing of those exons that code for in- 
tracellular peptide segments. A novel N-CAM has been de- 
scribed recently in human skeletal muscle where the ssd 
form contains a previously unidentified 37-amino acid ex- 
tracellular domain (Dickson et al., 1987). This may compare 
with the  TM1-  and  TM3-specific  "half' disulfide-loop in 
these forms of CEA. 
Alternative forms of the cytoplasmic region of N-CAM 
and L-MAG are derived by appropriate splice selection of in- 
frame exons (Cunningham et al., 1987; Salzer et al., 1987). 
In contrast, TM3-CEA and the proposed TM4-CEA contain 
a short but novel cytoplasmic peptide generated by a splice 
that results in out-of-frame translation. With this splice, the 
coding  sequence  for TM1/2-CEA  cytoplasmic region be- 
comes the 3' UTR and also contains the consensus polyade- 
nylation sequence (Figs. 2 and 3). To our knowledge, this re- 
sult is unique among alternatively spliced RNAs.  Unusual 
alternate COOH-terminal splices accompany the synthesis of 
the glial and endothelial cell forms of  platelet-derived growth 
factor A chain (Tong et al., 1987; Bonthron et al., 1987) and 
of the hydrophobic and hydrophilic termini of decay acceler- 
ating factor (Caras et al., 1987), but in each case, the 3' un- 
translated sequence and polyadenylation site remains con- 
stant. 
The cytoplasmic domain of TM-CEA is unique, as it is 
represented as a single band in Southern bl0t genomic analy- 
sis and bears no significant resemblance to other CEA- or 
non-CEA-related sequences based on computer-aided searches 
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Figure 7. Amino acid similarity in the cytoplasmic region of immu- 
noglobulin gene superfamily members,  L-MAG and  TM-CEA. 
The carboxyl-terminal residues of L-MAG and TMI-/TM2-CEA 
are shown; the absolute COOH-terminus for each is on the right. 
Regions of identity or similarity are indicated, respectively, by a 
solid line (I) or an asterisk (.) extending between compared resi- 
dues. For best physical alignment, deletion of some amino acids in 
TM-CEA relative to L-MAG is required; this is indicated by ,~. 
of the GenBank or EMBL data bases, or by direct compari- 
son of 20 different immunoglobulin superfamily members. 
However, a segment of limited similarity has been detected 
between the COOH-terminal 44 amino acids of the TM1/ 
TM2-CEA cytoplasmic domain and the COOH-terminal 38 
amino acids of the L-MAG cytoplasmic domain (19/38 ami- 
no acids; Fig. 7). This cytoplasmic segment is relatively high 
in amino acids that are potential substrates for phosphoryla- 
tion i.e.,  serine,  threonine, and tyrosine (13/48  residues), 
and it is largely these amino acids that are shared between 
the molecules. Consensus signals for associated enzymatic 
activities like tyrosine kinase (Bairoch and Claviere, 1988) 
are not found. 
In Fig. 8, we illustrate our interpretation of the extensive 
structural similarity among CEA isoantigens using immuno- 
globulin molecules as a model for their organization (Hun- 
kapiller  and Hood,  1986).  CEA  isoantigens  are depicted 
l 
NCA  CEA  TM1  TM2  TM3  TM4 
TM1  TM2-TM1 
homodlmet  heterodlmer 
Figure 8. Hypothetical single chain and dimer forms of CEA isoan- 
tigens as immunoglobulin-like molecules. Each CEA family mem- 
ber is depicted with extracellular disulfide loops and is embedded 
in the lipid bilayer via phosphoinositol linkage (for CEA and NCA) 
or is an integral cell surface molecule (for TM-CEAs). Some TM- 
CEA members are depicted as homo- or heterodimers. 
as membrane bound: for CEA and NCA, the membrane at- 
tachment may occur via a  phosphoinositol glycan moiety 
(Takami et al.,  1988), while the TM-CEAs have structural 
domains that make them integral membrane glycoproteins. 
While we depict all CEA isoantigens as single polypeptide 
chains,  sequence analysis of the  TM-CEAs indicates that 
these proteins have the potential to exist in vivo as cell sur- 
face homo- or heterodimers. LD I of TM-CEAs contains a 
single cysteine residue (amino acid position 308; Fig. 2) that 
may not be involved in intrachain disulfide linkage and there- 
fore by analogy, TM-CEA homodimers and heterodimers 
are depicted as immunoglobulin-like in surface character. 
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Note Added in Proof: Hinoda et al. (1988.  Proc. Natl. Acad. Sci. USA. 
84:5350-5354)  recently described the sequence of biliary glycoprotein I 
(BGP-I) which appears virtually identical to TM1-CEA. There are several 
significant differences between BGP-I mRNA and TMI-CEA mRNA de- 
scribed here. These include a shortened BGP-I cytoplasmic coding region 
which is attributable to a single nucleotide deletion at their position 1,401, 
a completely unrelated 3' UTR when compared to TM1-CEA, and drasti- 
cally different Northern blot patterns when using unique cDNA segments. 
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